Incidence estimate of nonmelanoma skin cancer in the United States, 2006

Archives of Dermatology

Volumn 146, Issue 3, 2010, Pages 283-287

  Rogers, Howard W ^a   Weinstock, Martin A ^b   Harris, Ashlynne R ^b   Hinckley, Michael R ^c   Feldman, Steven R ^c   Fleischer, Alan B ^c   Coldiron, Brett M ^d  

^a Advanced Dermatology   (United States)

^b BROWN UNIVERSITY   (United States)

^c WAKE FOREST SCHOOL OF MEDICINE   (United States)

^d UNIVERSITY OF CINCINNATI MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER EPIDEMIOLOGY; CANCER INCIDENCE; CONTROLLED STUDY; HEALTH SERVICE; HUMAN; MAJOR CLINICAL STUDY; PRIORITY JOURNAL; SKIN CANCER; UNITED STATES;

AGED; CROSS-SECTIONAL STUDIES; HUMANS; INCIDENCE; MEDICARE; POPULATION SURVEILLANCE; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SKIN NEOPLASMS; UNITED STATES;

EID: 77949405816     PISSN: 0003987X     EISSN: 15383652     Source Type: Journal    
DOI: 10.1001/archdermatol.2010.19     Document Type: Article

References (31)

1. Miller DL, Weinstock MA. Nonmelanoma skin cancer in the United States: incidence. J Am Acad Dermatol. 1994;30(5, pt 1):774-778.
2. American Cancer Society home page. http://www.cancer.org/docroot/home/ index.asp. Accessed September 27, 2009.
3. Christenson LJ, Borrowman TA, Vachon CM, et al. Incidence of basal cell and squamous cell carcinomas in a population younger than 40 years. JAMA. 2005; 294(6):681-690.
4. Karagas MR, Greenberg ER, Spencer SK, Stukel TA, Mott LA; New Hampshire Skin Cancer Study Group. Increase in incidence rates of basal cell and squamous cell skin cancer in New Hampshire, USA. Int J Cancer. 1999;81(4):555-559.
5. Glass AG, Hoover RN. The emerging epidemic of melanoma and squamous cell skin cancer. JAMA. 1989;262(15):2097-2100.
6. Athas WF, Hunt WC, Key CR. Changes in nonmelanoma skin cancer incidence between 1977-1978 and 1998-1999 in Northcentral New Mexico. Cancer Epidemiol Biomarkers Prev. 2003;12(10):1105-1108.
7. Swetter SM, Boldrick JC, Jung SY, Egbert BM, Harvell JD. Increasing incidence of lentigo maligna melanoma subtypes: northern California and national trends 1990-2000. J Invest Dermatol. 2005;125(4):685-691.
8. Insinga RP, Reither EN, Remington PL, Stephenson-Vine L. Trends in malignant melanoma incidence and mortality in Wisconsin, 1979-1997. WMJ. 2001;100 (6):27-31.
9. Jemal A, Devesa SS, Hartge P, Tucker MA. Recent trends in cutaneous melanoma incidence among whites in the United States. J Natl Cancer Inst. 2001; 93(9):678-683.
10. Harris RB, Griffith K, Moon TE. Trends in the incidence of nonmelanoma skin cancers in southeastern Arizona, 1985-1996. J Am Acad Dermatol. 2001;45 (4):528-536.
11. Brewster DH, Bhatti LA, Inglis JH, Nairn ER, Doherty VR. Recent trends in incidence of nonmelanoma skin cancers in the East of Scotland, 1992-2003. Br J Dermatol. 2007;156(6):1295-1300.
12. Staples MP, Elwood M, Burton RC, Williams JL, Marks R, Giles GG. Non melanoma skin cancer in Australia: the 2002 national survey and trends since 1985. Med J Aust. 2006;184(1):6-10.
13. Hayes RC, Leonfellner S, Pilgrim W, Liu J, Keeling DN. Incidence of nonmelanoma skin cancer in New Brunswick, Canada, 1992 to 2001. J Cutan Med Surg. 2007;11(2):45-52.
14. Demers AA, Nugent Z, Mihalcioiu C, Wiseman MC, Kliewer EV. Trends of nonmelanoma skin cancer from 1960 through 2000 in a Canadian population. J Am Acad Dermatol. 2005;53(2):320-328.
15. Wassberg C, Thörn M, Johansson AM, Bergström R, Berne B, Ringborg U. Increasing incidence rates of squamous cell carcinoma of the skin in Sweden. Acta Derm Venereol. 2001;81(4):268-272.
16. Housman TS, Feldman SR, Williford PM, et al. Skin cancer is among the most costly of all cancers to treat for the Medicare population. J Am Acad Dermatol. 2003;48(3):425-429.
17. Joseph AK, Mark TL, Mueller C. The period prevalence and costs of treating nonmelanoma skin cancers in patients over 65 years of age covered by Medicare. Dermatol Surg. 2001;27(11):955-959.
18. Physician/Supplier Procedure Summary Master File. Centers for Medicare and Medicaid Services Web site. http://www.cms.hhs.gov/NonIdentifiableDataFiles/ 06-PhysicianSupplierProcedureSummaryMasterFile.asp. Accessed September 27, 2009.
19. Overview. Centers for Medicare and Medicaid Services Web site. http://www.cms.hhs.gov/MedHCPCSGeninfo/. Accessed September 27, 2009.
20. ICD-9-CM Official Guidelines for Coding and Reporting. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/nchs/data/icd9/ icdguide.pdf. Accessed September 27, 2009.
21. Standard Analytical Files: Limited Data Sets. Centers for Medicare and Medicaid Services Web site. http://www.cms.hhs.gov/LimitedDataSets/12- StandardAnalyticalFiles.asp. Accessed September 27, 2009.
22. Ambulatory health care data. Centers for Disease Control and Prevention Web site. http://www.cdc.gov/nchs/ahcd.htm. Accessed September 27, 2009.
23. Jemal A, Siegel R, Ward E, et al. Cancer statistics, 2006. CA Cancer J Clin. 2008; 58(2):71-96.
24. 2007 annual report of the boards of trustees of the federal hospital insurance and federal supplementary medical insurance trust funds. Centers for Medicare and Medicaid Services Web site. http://www.cms.hhs.gov/ ReportsTrustFunds/downloads/tr2007.pdf. Accessed September 27, 2009.
25. Population estimates. US Census Bureau Web site. http://www.census.gov/ popest/national/asrh/NC-EST2007-sa.html. Accessed September 27, 2009.
26. Method A. The Skin Cancer Center Web site. http://www. theskincancercenter.net/images/Method%20A.pdf. Accessed September 27, 2009.
27. Method B. The Skin Cancer Center Web site. http://www. theskincancercenter.net/images/Method%20B.pdf. Accessed September 27, 2009.
28. Skin cancer. The National Cancer Institute Web site. http://www.cancer. gov/cancertopics/types/skin. Accessed September 27, 2009.
29. Bickers DR, Lim HW, Margolis D, et al; American Academy of Dermatology Association; Society for Investigative Dermatology. The burden of skin diseases: 2004 a joint project of the American Academy of Dermatology Association and the Society for Investigative Dermatology. J Am Acad Dermatol. 2006; 55(3):490-500.
30. Rogers HW, Coldiron BM. A relative value unit-based cost comparison of treatment modalities for nonmelanoma skin cancer: effect of the loss of the Mohs multiple surgery reduction exemption. J Am Acad Dermatol. 2009;61(1):96-103.
31. Weinstock MA. The struggle for primary prevention of skin cancer. Am J Prev Med. 2008;34(2):171-172.